IL34 and Alzheimer disease: We first sought to verify the expression of IL-34 by both cell types to provide support for the underlying hypothesis of this work: that monocyte-derived macrophages infiltrating the CNS in the context of AD may be exposed to IL-34 produced by different cell types, which may ultimately influence their phenotype and ability to clear Aβ.